My 2023 biotech outlook requires continued momentum in title modifications. I simply want to determine what the shares will do.

Final yr, Respira Applied sciences turned Qnovia. It’s run by a former tobacco government with vape expertise, and it’s creating an inhaled nicotine platform for quitting smoking. On one hand, I discovered years in the past {that a} fairly good platform for that’s simply to not inhale any extra nicotine. However then again, going from Q straight to N in an organization title sounds clinically promising.